ロード中...
Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom
New therapeutic options in breast cancer have improved survival but consequently increase the relevance of late complications. Ovarian suppression/ablation and aromatase inhibitors (AI) in the adjuvant setting have improved outcome, but have clinically important adverse effects on bone health. Howev...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2006
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361086/ https://ncbi.nlm.nih.gov/pubmed/16317429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602892 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|